Northwestern Mutual Wealth Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67K Buy
151
+1
+0.7% +$9 ﹤0.01% 3651
2025
Q4
$801 Hold
150
﹤0.01% 3667
2025
Q3
$1.32K Hold
150
﹤0.01% 3484
2025
Q2
$1.05K Hold
150
﹤0.01% 3376
2025
Q1
$1.64K Hold
150
﹤0.01% 3196
2024
Q4
$1.5K Hold
150
﹤0.01% 3234
2024
Q3
$2.48K Hold
150
﹤0.01% 3077
2024
Q2
$1.67K Hold
150
﹤0.01% 3139
2024
Q1
$1.98K Buy
+150
New +$1.95K ﹤0.01% 3053
2015
Q4
Sell
-6
Closed -$9K 1717
2015
Q3
$9K Buy
+6
New +$30K ﹤0.01% 1108

Other funds holding IMUX

Northwestern Mutual Wealth Management's IMUX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Immunic (IMUX) stake by 0.67% in Q1 2026, buying an estimated $9 and bringing the position to 151 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

Northwestern Mutual Wealth Management first reported a position in IMUX in Q3 2015 and has held it in 10 quarters since. The position peaked at $9K in Q3 2015. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 151 shares of Immunic worth $1.67K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 1 Immunic share in Q1 2026, an estimated $9.
  • Immunic made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3651 holding.
  • Northwestern Mutual Wealth Management first reported a position in Immunic in Q3 2015 and has held it in 10 quarters since.
  • Northwestern Mutual Wealth Management's Immunic position peaked at $9K in Q3 2015.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.